C. Frank Bennett - Concepedia

Author

C. Frank Bennett

Ionis Pharmaceuticals (United States)ORCID

Also Known As

Bennett, C.F., C Bennett, C F BENNETT, C F Bennett, C Frank Bennett, C. Frank Bennett, C. Bennett, C. F. BENNETT, C. F. Bennett, C. FRANK BENNETT

329

Publications

46.4K

Citations

100

H-Index

211

Concepts

All Affiliations

Ionis Pharmaceuticals (United States)Cold Spring Harbor Laboratory University of California San Diego Ludwig Cancer Research Biogen (United States)

About

C. Frank Bennett is an author at Ionis Pharmaceuticals (United States) specializing in medicine, cell biology, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	61	108	23.3K
2	Natural Sciences	29	33	6.9K
3	Engineering	10	10	2.1K
4	Social Sciences	6	6	1.8K
5	Health Sciences	4	4	431

C. Frank Bennett

197

Publications

39.5K

Citations

H-Index

Page 1

	Year	Citations
The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation Vidisha Tripathi, Jonathan D. Ellis, Zhen Shen, Molecular Cell Transcriptional RegulationGeneticsRna Binding ProteinsRna SplicingRna Biology	2010	2.2K
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy Richard S. Finkel, Eugenio Mercuri, Basil T. Darras, New England Journal of Medicine	2017	2.2K
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting Christine Esau, Scott Davis, Susan Murray, Cell Metabolism Mir-122 RegulationMolecular PhysiologyLipid SynthesisLipid MetabolismMedicine	2006	2K
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy Eugenio Mercuri, Basil T. Darras, Claudia A. Chiriboga, New England Journal of Medicine	2018	1.4K
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43 Magdalini Polymenidou, Clotilde Lagier‐Tourenne, Kasey R. Hutt, Nature Neuroscience Neuronal VulnerabilityMolecular NeuroscienceMedicineLong Non-coding RnaNeuroprotection	2011	1.3K
MicroRNA-143 Regulates Adipocyte Differentiation Christine Esau, Xiaolin Kang, Eigen Peralta, Journal of Biological Chemistry	2004	1K
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study Richard S. Finkel, Claudia A. Chiriboga, Jiri Vajsar, The Lancet Dose-escalation StudySpinal Cord InjuryPediatric SpinePhase 2Neuromusculoskeletal Disorder	2016	998
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention Christopher J. Donnelly, Ping‐Wu Zhang, Jacqueline T. Pham, Neuron Rna ToxicityEngineeringRna BiologyMolecular BiologyAntisense Therapy	2013	875
Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis Holly Kordasiewicz, Lisa M. Stanek, Edward V. Wancewicz, Neuron Knockout MouseMolecular BiologyDegenerative DiseaseHuntingtin SynthesisTransient Repression	2012	758
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model Yimin Hua, Kentaro Sahashi, Frank Rigo, Nature Regenerative MedicineNeuroregenerationSpinal Cord InjuryPeripheral Nerve InjuryLong-term Rescue	2011	732

Page 1